Treatment effects of renin-angiotensin system inhibitor and calcium channel blocker in patients with coronary artery narrowing (from the Japanese Coronary Artery Disease Study)-Reference-Cited by-同舟云学术

Treatment effects of renin-angiotensin system inhibitor and calcium channel blocker in patients with coronary artery narrowing (from the Japanese Coronary Artery Disease Study)

Published:2010-10-05 Issue:6 Volume:25 Page:453-459
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Fujita Masatoshi, ,Sasayama Shigetake,Terasaki Fumio,Mitani Satoko,Morimoto Tatsuya,Yamazaki Tsutomu,Hayashi Doubun,Kohro Takahide,Okada Yoshihiro,Nagai Ryozo

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-010-0012-5.pdf

Reference14 articles.

1. Law MR, Wald NJ, Morris JK, Jordan RE (2003) Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. Br Med J 326:1427–1431

2. Neutel JM, Smith DHG, Weber MA (2001) Low-dose combination therapy: an important first-line treatment in the management of hypertension. Am J Hypertens 14:286–292

3. Flack JM, Calhoun DA, Satlin L, Barbier M, Hilkert R, Brunel P (2009) Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study. J Hum Hypertens 23:479–489

4. Ge CJ, Lu SZ, Chen YD, Wu XF, Hu SJ, Ji Y (2008) Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. Heart Vessels 23:91–95

5. Kuschair E, Acura E, Sevilla D (1996) Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 20 mg and placebo. Clin Ther 18:6–12

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of aliskiren on the fibrinolytic system in patients with coronary artery disease receiving angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor blocker;Heart and Vessels;2011-11-02